Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

ARWRARWR
Showing 8 of 30 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in ARROWHEAD PHARMACEUTICALS IN

NORTHERN TRUST CORP holds 1.2M shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $97.2M as of 2026-Q2. The position was decreased (-28.0% shares). ARWR represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$97.2M

Current Shares

1.2M

Total Value Change

+$71.4M

Total Shares Change

-139,897

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.2M
-28.0%
$97.2M0.0%$81.51
0
2026-Q1
Increased
1.7M
+23.0%
$103.8M0.0%$64.10
36
2025-Q4
Increased
1.3M
+2.6%
$89.4M0.0%$67.25
31
2025-Q3
Increased
1.3M
+3.1%
$45.2M0.0%$33.78
30
2025-Q2
Increased
1.3M
+5.1%
$20.1M0.0%$16.08
30
2025-Q1
Decreased
1.2M
-18.4%
$15.4M0.0%$13.82
0
2024-Q4
Increased
1.5M
+11.4%
$27.9M0.0%$18.61
32
2024-Q3
Increased
1.3M
+0.8%
$25.8M0.0%$19.67
29

Other major holders of ARWR: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used